Ann Schmierer, PhD
Ann’s role is to execute and manage industry research contracts to establish and maintain industry relationships with life science companies and related industries for Oregon State University. She works to promote industry-university research and serves as a resource for faculty. Ann actively promotes open innovation strategies and identifies translational research opportunities that align with company objectives. She also facilitates access to specialized facilities and resources for companies at OSU.
Her areas of expertise span technical and business areas: cell and tissue biology, immunology, medical devices, regenerative medicine, biopharmaceuticals, diagnostics, drug delivery strategies, material surface science, nanotechnology, combination products, translational research, intellectual property protection, bioscience commercialization, medical regulatory policy, and medical market analysis.
Before arriving at OSU, she was a technical industry liaison for 12 years at the Georgia Institute of Technology (Georgia Tech). Most recently she was the Director of Biosciences within the Strategic Partners Office at the Georgia Tech Enterprise Innovation Institute.
Dr. Schmierer has been a member of two National Science Foundation Engineering Research Centers (ERCs). She was the Manager for Industrial Relations and Technology Transfer at the Georgia Tech/Emory Center (GTEC) for Regenerative Medicine (2000-2006). She was also instrumental in the establishment and management of the University of Washington Engineered Biomaterials ERC. She worked at Immunex Corporation (now Amgen) where she performed cytokine and hematopoietic stem cell research and development, working primarily on the discovery, purification, manufacturing of interleukin-7 that generated patents and revenue for Immunex.
University of Washington, Ph.D. Bioengineering